Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries, as well as develops cell and gene therapies. The company also provides drinking water sanitizers, nutraceuticals, antidandruff agents, and other personal care ingredients; and agricultural products and advanced coatings and composites, as well as microbial control solutions that combat dangerous viruses, bacteria, and other pathogens. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Часто задаваемые вопросы
В каком секторе работает Lonza Group Ltd (LONN)?
Lonza Group Ltd относится к сектору Материалы.
Какова текущая цена акций Lonza Group Ltd (LONN)?
По последним данным, цена акций Lonza Group Ltd составляет 0,00 CHF, предыдущее закрытие — 0,00 CHF.
Выплачивает ли Lonza Group Ltd (LONN) дивиденды?
Нет, Lonza Group Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Lonza Group Ltd (LONN)?
У компании Lonza Group Ltd бета 0.408, что указывает на более низкую волатильность по сравнению с рынком в целом.
